Vaccinia Vectors as Candidate Vaccines: The Development of Modified Vaccinia Virus Ankara for Antigen Delivery

Publisher： Bentham Science Publishers

E-ISSN： 1875-5852|3|3|263-271

ISSN： 1568-0053

Source： Current Drug Targets - Infectious Disorders, Vol.3, Iss.3, 2003-09, pp. : 263-271

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Environmental Risk Assessment of Clinical Trials Involving Modified Vaccinia Virus Ankara (MVA)-Based Vectors

By  

Current Gene Therapy, Vol. 13, Iss. 6, 2013-12 ,pp. : 413-420

Bentham Science Publishers

Access to resources Recommend Favorite

Vaccinia Viral / Retroviral Chimeric Vectors

By  

Current Gene Therapy, Vol. 4, Iss. 4, 2004-12 ,pp. : 417-426

Bentham Science Publishers

Access to resources Recommend Favorite

Zoonotic vaccinia virus outbreaks in Brazil

By da Fonseca Flávio Guimarães   Kroon Erna Geessien   Nogueira Maurício Lacerda   de Souza Trindade Giliane  

Future Virology, Vol. 6, Iss. 6, 2011-06 ,pp. : 697-707

Future Medicine

Access to resources Recommend Favorite

Adaptive immunity to vaccinia virus: revisiting an old friend

By Tscharke David C  

Future Virology, Vol. 2, Iss. 2, 2007-03 ,pp. : 163-172

Future Medicine

Access to resources Recommend Favorite

Oncolytic vaccinia virus: a theranostic agent for cancer

By Chen Nanhai G   Szalay Aladar A  

Future Virology, Vol. 5, Iss. 6, 2010-11 ,pp. : 763-784

Future Medicine

Access to resources Recommend Favorite